Lip Augmentation Market Research Report – Global Forecast till 2027

Lip Augmentation Market Research Report: By Type (Temporary and Permanent Lip Augmentation), Lip Fillers (Fat Injection or Lipoinjection, Hyaluronic Acid Fillers, Lip Collagen Injections & Others), Distribution Channel – Global Forecast Till 2027

ID: MRFR/HC/5762-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Global lip augmentation market is expected to grow significantly over the forecast period. It is projected to grow at a CAGR of 10.5% over the forecast period. 


Lip augmentation is a cosmetic procedure which is used to get fuller and plumper lips. Hyaluronic acid based-dermal fillers are mostly preferred for lip augmentation.


Rising participation of market players and development of medical tourism industry are the prominent factors driving the lip augmentation market. For instance, in 2018, Allergan plc launched a new JUVÉDERM advertising campaign created to empower the next generation of consumers to "JUVÉDERM IT." The JUVÉDERM collection of fillers offers a complete range of dermal fillers for different patient needs. JUVÉDERM Ultra XC is used into the lips and perioral area for lip augmentation in adults over 21. Moreover, in 2017, Allergan plc acquired LifeCell Corporation, a leading regenerative medicine company, for approximately USD 2.9 billion in cash.


Various other factors such as increasing awareness about lip augmenation, rising geriatric population and rising demand for dermal fillers are also expected to propel the growth of the market.


However, side effects associated with lip fillers and high cost of treatment can hamper the market growth over the forecast period.


Segmentation


The global lip augmentation market is segmented based on type, lip fillers, distribution channel, and region.


The global market for lip augmentation, by type is segmented into temporary lip augmentation and permanent lip augmentation. The permanent lip augmentation segment is further classified as dermal graft, permanent lip implants, vermilion lip advancement and lip lift. The lip lift segment includes corner lip lift and upper lip lift.


The market, by lip fillers, is segmented into fat injection or lipoinjection, hyaluronic acid fillers, lip collagen injections, platelet-rich plasma (PRP), and others.


Based on distribution channel, the market is segmented into hospital pharmacies, clinics, retail pharmacies, drug stores, online pharmacies, and others.


The hospital pharmacies segment is anticipated to hold the largest market share owing to the increasing demand for cosmetic procedures. The online pharmacies are expected to grow at the highest CAGR owing to the rising cases of cosmetic problems.


In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.


The lip augmentation market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European lip augmentation market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The lip augmentation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The lip augmentation market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Lip Augmentation market Share (%), by Region, 2017



Sources: MRFR Analysis


The Americas dominated the global market for lip augmentation owing to the rising geriatric population. According to the Population Reference Bureau report, the number of Americans ages 65 and older is projected to double from 46 million today to over 98 million by 2060. Moreover, rising healthcare spending within the region is also boosting the lip augmentation market. In the US, the total healthcare spending reached USD 3.5 trillion in 2017 and by 2026; it is expected to reach USD 5.7 trillion.


In 2017, it was estimated that Europe stood second in the global lip augmentation market. This can be attributed to the rising research and development investments and technological advancements. For instance, in 2017, Allergan received FDA approval for its newest hyaluronic acid dermal filler, Juvéderm Vollure XC.


Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing medical tourism industry and increasing technological advancements within the region are boosting the regional markets of the Asia Pacific region.


On the other hand, the Middle East and Africa held least share in the global lip augmentation market due to the low per capita income, especially within the African region.


Key players


Some of the key players in the global lip augmentation market are Allergan, Galderma Pharma S.A., Integra Lifesciences, Laboratories Vivacy SAS, Merz Pharma, Sinclair Pharma, Suneva Medical, Inc, Teoxane, Cynosure, Syneron, AQTIS Medical, Bioha Laboratories, Cytophil, Inc., Dr. Korman Laboratories, Inamed Corporation, and Anika Therapeutics Inc., and others.


Research Methodology


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  • Primary Research


Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the lip augmentation. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.


Intended Audience



  • Pharmaceutical Companies

  • Government and Private Laboratories

  • Research and Development (R&D) companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers


Market Segmentation and Key Market Players


Global Lip Augmentation Market, by Type



  • Temporary Lip Augmentation

  • Permanent Lip Augmentation

    • Dermal Graft

    • Permanent Lip Implants

    • Vermilion Lip Advancement

    • Lip Lift

      • Corner Lip Lift

      • Upper Lip Lift






Global Lip Augmentation Market, by Lip Fillers



  • Fat Injection or Lipoinjection

  • Hyaluronic Acid Fillers

  • Lip Collagen Injections

  • Platelet-rich Plasma (PRP)

  • Others


Global Lip Augmentation Market, by Distribution Channel



  • Hospital Pharmacies

  • Clinics 

  • Retail Pharmacies 

  • Drug Stores

  • Online Pharmacies

  • Others

 



Frequently Asked Questions (FAQ) :


Lip Augmentation Market would grow with a 10.5% CAGR during the forecast period of 2018 to 2023.

High cost and side-effects could prevent the Lip Augmentation Market growth.

Lip Augmentation Market has distribution channels like clinics, hospital pharmacies, drug stores, online pharmacies, retail pharmacies, and others.

Lip Augmentation Market has lip fillers like hyaluronic acid fillers, fat injection or lipo injection, platelet-rich plasma (PRP), lip collagen injections, and others.

Americas would dominate the Lip Augmentation Market.

Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Lip Augmentation Market, by Type

6.1 Introduction

6.2 Temporary Lip Augmentation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Permanent Lip Augmentation

6.3.1 Dermal Graft

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2 Permanent Lip Implants

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.3 Vermilion Lip Advancement

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.4 Lip Lift

6.3.4.1 Corner Lip Lift

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.4.2 Upper Lip Lift

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Lip Augmentation Market, by Lip Fillers

7.1 Introduction

7.2 Fat Injection or Lipoinjection

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Hyaluronic Acid Fillers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Lip Collagen Injections

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Platelet-rich Plasma (PRP)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Lip Augmentation Market, by Distribution Channel

8.1 Introduction

8.2 Hospital Pharmacies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Retail Pharmacies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Drug Stores

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6 Online Pharmacies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Lip Augmentation Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Allergan

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Galderma Pharma S.A.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Integra Lifesciences

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Laboratoire Vivacy SAS

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Inamed Corporation

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Merz Pharma

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Sinclair Pharma

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Suneva Medical, Inc

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Teoxane

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Cynosure

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Syneron

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 AQTIS Medical

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Bioha Laboratories

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Cytophil, Inc.

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Dr. Korman Laboratories

11.15.1 Overview

11.15.2 Product Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

11.16 Other

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictionsfor the global lip augmentation market

Chapter 13. Appendix

LIST OF TABLES

Table 1 Lip Augmentation Market Synopsis, 2020-2027

Table 2 Lip Augmentation Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Lip Augmentation Market, by Region, 2020-2027 (USD Million)

Table 4 Global Lip Augmentation Market, by Type, 2020-2027 (USD Million)

Table 5 Global Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

Table 6 Global Lip Augmentation Market, Distribution Channel, 2020-2027 (USD Million)

Table 7 North America: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

Table 8 North America: Lip Augmentation Market, by Lip Fillers, 2020-2027(USD Million)

Table 9 North America: Lip Augmentation Market, Distribution Channel, 2020-2027 (USDMillion)

Table 10 US: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

Table 11 US: Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

Table 12 US: Lip Augmentation Market, Distribution Channel, 2020-2027 (USD Million)

Table 13 Canada:Lip Augmentation Market,byType, 2020-2027 (USD Million)

Table 14 Canada: Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

Table 15 Canada: Lip Augmentation Market, Distribution Channel, 2020-2027 (USDMillion)

Table 16 South America: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

Table 17 South America: Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

Table 18 South America: Lip Augmentation Market, Distribution Channel, 2020-2027 (USDMillion)

Table 19 Europe: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

Table 20 Europe: Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

Table 21 Europe: Lip Augmentation Market, Distribution Channel, 2020-2027 (USD Million)

Table 22 Western Europe: Lip Augmentation Market, by Type, 2020-2027 (USDMillion)

Table 23 Western Europe: Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

Table 24 Western Europe: Lip Augmentation Market, by Distribution Channel, 2020-2027(USD Million)

Table 25 Eastern Europe: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

Table 26 Eastern Europe: Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

Table 27 Eastern Europe: Lip Augmentation Market, Distribution Channel, 2020-2027(USD Million)

Table 28 Asia-Pacific: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

Table 29 Asia-Pacific: Lip Augmentation Market,by Lip Fillers, 2020-2027 (USD Million)

Table 30 Asia-Pacific: Lip Augmentation Market, Distribution Channel, 2020-2027 (USD Million)

Table 31 Middle East & Africa: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

Table 32 Middle East & Africa: Lip Augmentation Market, by Lip Fillers,2020-2027 (USD Million)

Table 33 Middle East & Africa: Lip Augmentation Market, Distribution Channel, 2020-2027(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Lip Augmentation Market

Figure 3 Market Dynamics for Global Lip Augmentation Market

Figure 4 Lip Augmentation Market Share, by Type,2020

Figure 5 Lip Augmentation Market Share, by Lip Fillers,2020

Figure 6 Lip Augmentation Market Share, Distribution Channel, 2020

Figure 7 Lip Augmentation Market Share, by Region, 2020

Figure 8 North America: Lip Augmentation Market Share, by Country, 2020

Figure 9 Europe: Lip Augmentation Market Share, by Country, 2020

Figure 10 Asia-Pacific: Lip Augmentation Market Share, by Country, 2020

Figure 11 Middle East & Africa: Lip Augmentation Market Share, by Region, 2020

Figure 12 Lip Augmentation Market : Company Share Analysis, 2020 (%)

Figure 13 Allergan: Key Financials

Figure 14 Allergan: Segmental Revenue

Figure 15 Allergan: Geographical Revenue

Figure 16 Galderma Pharma S.A. : Key Financials

Figure 17 Galderma Pharma S.A. : Segmental Revenue

Figure 18 Galderma Pharma S.A. : Geographical Revenue

Figure 19 Integra Lifesciences:Key Financials

Figure 20 Integra Lifesciences: Segmental Revenue

Figure 21 Integra Lifesciences: Geographical Revenue

Figure 22 Laboratoire Vivacy SAS: Key Financials

Figure 23 Laboratoire Vivacy SAS: Segmental Revenue

Figure 24 Laboratoire Vivacy SAS: Geographical Revenue

Figure 25 Inamed Corporation:Key Financials

Figure 26 Inamed Corporation: Segmental Revenue

Figure 27 Inamed Corporation: Geographical Revenue

Figure 28 Merz Pharma: Key Financials

Figure 29 Merz Pharma: Segmental Revenue

Figure 30 Merz Pharma: Geographical Revenue

Figure 31 Sinclair Pharma: Key Financials

Figure 32 Sinclair Pharma: Segmental Revenue

Figure 33 Sinclair Pharma: Geographical Revenue

Figure 34 Suneva Medical, Inc:Key Financials

Figure 35 Suneva Medical, Inc: Segmental Revenue

Figure 36 Suneva Medical, Inc: Geographical Revenue

Figure 37 Teoxane: Key Financials

Figure 38 Teoxane: Segmental Revenue

Figure 39 Teoxane: Geographical Revenue

Figure 40 Cynosure: Key Financials

Figure 41 Cynosure: Segmental Revenue

Figure 42 Cynosure: Geographical Revenue

Figure 43 Syneron : Key Financials

Figure 44 Syneron :Segmental Revenue

Figure 45 Syneron : Geographical Revenue

Figure 46 AQTIS Medical: Key Financials

Figure 47 AQTIS Medical: Segmental Revenue

Figure 48 AQTIS Medical: Geographical Revenue

Figure 49 Bioha Laboratories: Key Financials

Figure 50 Bioha Laboratories: Segmental Revenue

Figure 51 Bioha Laboratories: Geographical Revenue

Figure 52 Cytophil, Inc.: Key Financials

Figure 53 Cytophil, Inc.: Segmental Revenue

Figure 54 Cytophil, Inc.: Geographical Revenue

Figure 55 Dr. Korman Laboratories: Key Financials

Figure 56 Dr. Korman Laboratories: Segmental Revenue

Figure 57 Dr. Korman Laboratories: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.